- Home
- EYPT vs HIVE Comparison
EYPT vs HIVE Comparison
Compare EYPT & HIVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EYPT
- HIVE
- Stock Information
- Founded
- EYPT 1987
- HIVE 1987
- Country
- EYPT United States
- HIVE United States
- Employees
- EYPT N/A
- HIVE N/A
- Industry
- EYPT Biotechnology: Laboratory Analytical Instruments
- HIVE
- Sector
- EYPT Industrials
- HIVE
- Exchange
- EYPT Nasdaq
- HIVE Nasdaq
- Market Cap
- EYPT 579.4M
- HIVE 510.0M
- IPO Year
- EYPT 2005
- HIVE N/A
- Fundamental
- Price
- EYPT $10.48
- HIVE $2.27
- Analyst Decision
- EYPT Strong Buy
- HIVE Strong Buy
- Analyst Count
- EYPT 8
- HIVE 7
- Target Price
- EYPT $24.75
- HIVE $6.57
- AVG Volume (30 Days)
- EYPT 729.0K
- HIVE 30.2M
- Earning Date
- EYPT 08-06-2025
- HIVE 08-11-2025
- Dividend Yield
- EYPT N/A
- HIVE N/A
- EPS Growth
- EYPT N/A
- HIVE N/A
- EPS
- EYPT N/A
- HIVE N/A
- Revenue
- EYPT $56,042,000.00
- HIVE $115,279,000.00
- Revenue This Year
- EYPT N/A
- HIVE $167.38
- Revenue Next Year
- EYPT N/A
- HIVE $68.08
- P/E Ratio
- EYPT N/A
- HIVE N/A
- Revenue Growth
- EYPT 12.04
- HIVE 0.71
- 52 Week Low
- EYPT $3.91
- HIVE $1.26
- 52 Week High
- EYPT $13.99
- HIVE $5.54
- Technical
- Relative Strength Index (RSI)
- EYPT 59.34
- HIVE 55.56
- Support Level
- EYPT $10.26
- HIVE $2.15
- Resistance Level
- EYPT $11.00
- HIVE $2.54
- Average True Range (ATR)
- EYPT 0.64
- HIVE 0.18
- MACD
- EYPT -0.07
- HIVE 0.00
- Stochastic Oscillator
- EYPT 42.11
- HIVE 40.00
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.
About HIVE HIVE Digital Technologies Ltd.
HIVE Digital Technologies Ltd is in the business of providing infrastructure solutions in the blockchain industry. It focuses on the mining and sale of digital currencies. Its geographical segments include Canada, Sweden, Iceland, Switzerland, and Bermuda, out of which the majority of the revenue comes from Bermuda.